ShopSpell

Ex Vivo Engineering of the Tumor Microenvironment [Hardcover]

$137.99     $169.99    19% Off      (Free Shipping)
100 available
  • Category: Books (Medical)
  • ISBN-10:  3319453955
  • ISBN-10:  3319453955
  • ISBN-13:  9783319453958
  • ISBN-13:  9783319453958
  • Publisher:  Humana
  • Publisher:  Humana
  • Binding:  Hardcover
  • Binding:  Hardcover
  • Pub Date:  01-Apr-2016
  • Pub Date:  01-Apr-2016
  • SKU:  3319453955-11-SPRI
  • SKU:  3319453955-11-SPRI
  • Item ID: 100190906
  • List Price: $169.99
  • Seller: ShopSpell
  • Ships in: 5 business days
  • Transit time: Up to 5 business days
  • Delivery by: Jul 08 to Jul 10
  • Notes: Brand New Book. Order Now.

This volume will outline how to recreate the tumor microenvironment, to culture primary tumors without the need for developmental priming factors, and to deliver targeted therapeutics in a manner that recapitulates pharmacokinetics in vivo. Much of what may be learned from this volume will aid in understanding many aspects of the enhanced study of tumor cell biology in a physiologic context, open new avenues for drug screening and biomarker development, and accelerate the preclinical evaluation of novel personalized medicine strategies for patients in real time.

This volume will outline how to recreate the tumor microenvironment, to culture primary tumors without the need for developmental priming factors, and to deliver targeted therapeutics in a manner that recapitulates pharmacokinetics in vivo. Much of what may be learned from this volume will aid in understanding many aspects of the enhanced study of tumor cell biology in a physiologic context, open new avenues for drug screening and biomarker development, and accelerate the preclinical evaluation of novel personalized medicine strategies for patients in real time.Amir R. Aref, PhD, is Instructor, Dana-Farber Cancer Institute, Harvard Medical School.This volume will outline how to recreate the tumor microenvironment, to culture primary tumors without the need for developmental priming factors, and to deliver targeted therapeutics in a manner that recapitulates pharmacokinetics in vivo. Much of what may be learned from this volume will aid in understanding many aspects of the enhanced study of tumor cell biology in a physiologic context, open new avenues for drug screening and biomarker development, and accelerate the preclinical evaluation of novel personalized medicine strategies for patients in real time.

Outlines how to recreate the tumor microenvironment, to culture primary tumors without the need fl£—

Add Review